Staar Surgical Company (STAA) Stock Price, Quote & News

Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 626 303 7902

Fax: 626 359 8402

Website: www.staar.com

Address:

25510 Commercentre Drive, Lake Forest, United States

BioTuesdays Feb. 2 at 6:36 PM

$STAA has announced that its board of directors has appointed Warren Foust, president and CEO, and Deborah Andrews, CFO, as interim co-CEOs, effective yesterday https://biotuesdays.com/2026/02/02/staar-appoints-warren-foust-and-deborah-andrews-as-interim-co-ceos/

0 · Reply

Bogwood Feb. 2 at 3:59 PM

$LCTX $STAA $IMDX anyone else surprised at how much light is behind Neal's eyes? Thought he would've had a jaded death stare after dealing with these companies for so long lol

2 · Reply

Goblinvomit Jan. 30 at 8:42 PM

$STAA lol, glad I made out by selling then shorting this pig at $25.

1 · Reply

StockBraker Jan. 29 at 3:50 PM

$STAA May take a while to get back above $30, but given that Broadwood wants more than what Alcon was offering ($30.75) they will do everything in their power to get the share price up - either through another deal or organic share price appreciation. I would have been willing to have taken the Alcon offer, but I don't hold the cards and it's Dealer's choice. Might as well take advantage of these low prices. If we do get above $32 that's a minimum 68% ROI.

1 · Reply

OfficialStocktwitsUser Jan. 29 at 5:17 AM

$STAA RSI: 21.10, MACD: -1.3325 Vol: 1.55, MA20: 21.39, MA50: 23.74 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ffdseh Jan. 19 at 5:42 AM

$STAA Seems that one going on that we're going under the knife for eent and other surgeries and were also given pelvic exams, Without their knowlledge or concent. And had catheters inserted, to show interns and new medical staff. They never told rhe woman that this would be done to them. They may of went in for ent surgerymay have had any intention surgery.And while were having that, they were being taken advantage of by a line of gluved interns. Seems some states are beginning to STOP this procedure , while many others still do it. I believe this happened to my wife years ago in Boston. Cancel medical schools , training schools , training hospitals have been going out of the way to defend this practice for years. Is it just me or just a horrible , horrible , horrible practice

1 · Reply

BaroloBuff Jan. 19 at 1:58 AM

$STAA Greed & incompetence management kills most companies this size. Get out while you can.

0 · Reply

scalperD Jan. 18 at 4:26 PM

$STAA -probably the best small cap special sit play I've come across in a while. Broadwood and Yunqi get paid on returns. Either Alcon comes back higher or there is another interested party - like the risk/reward

1 · Reply

mbrandi Jan. 16 at 7:40 PM

$STAA Crazy price action today, I assume Broadwood will have swept up some more, but we'll see if the filings come through.

0 · Reply

StockBraker Jan. 16 at 3:26 PM

$STAA Board Shakeup https://www.tipranks.com/news/company-announcements/staar-surgical-appoints-new-board-chair-restructures-committees

0 · Reply

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

Jan 15, 2026, 1:06 PM EST - 19 days ago

STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence

Jan 15, 2026, 8:30 AM EST - 19 days ago

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

Jan 6, 2026, 8:00 PM EST - 4 weeks ago

Market Cap	942.61M
Revenue (ttm)	313.90M
Net Income (ttm)	-20.21M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.44%
Debt to Equity Ratio	0.00

Volume	1,381,700
Avg Vol	1,474,768
Day's Range	N/A - N/A
Shares Out	49.74M
Stochastic %K	13%
Beta	1.00
Analysts	Hold
Price Target	$23.92